Andrew T. Lucas

A Novel Heme-Regulatory Motif Mediates Heme-Dependent Degradation of the Circadian Factor Period 2

Jianhua Yang, Kevin D. Kim, Andrew T. Lucas et al. · Molecular and Cellular Biology · 2008 · 94 citations · Full text

Molecular Biology, Prevents Hper2, Redox Biology +19

A sensitive high performance liquid chromatography assay for the quantification of doxorubicin associated with DNA in tumor and tissues

Andrew T. Lucas, Sara O’Neal, Charlene Santos et al. · Journal of Pharmaceutical and Biomedical Analysis · 2015 · 40 citations · Full text

Oncology, Medicine, Bioanalysis +8

Biophysical and Molecular-Dynamics Studies of Phosphatidic Acid Binding by the Dvl-2 DEP Domain

Daniel G. S. Capelluto, Xiaolin Zhao, Andrew T. Lucas et al. · Biophysical Journal · 2014 · 26 citations · Full text

Proteinlipid Interaction, Biochemistry, Phosphatidic Acid Binding +9

A phase Ib/II and pharmacokinetic study of EP0057 (formerly CRLX101) in combination with weekly paclitaxel in patients with recurrent or persistent epithelial ovarian, fallopian tube, or primary peritoneal cancer

Linda Duska, Carolyn Krasner, David M. O’Malley et al. · Gynecologic Oncology · 2020 · 26 citations

Phase Ib/ii, Gastrointestinal Oncology, Medicine +8

Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2

Christina L. Parker, Morgan D. McSweeney, Andrew T. Lucas et al. · Nanomedicine Nanotechnology Biology and Medicine · 2019 · 23 citations

Cell-based Drug Delivery, Nanomedicine, Engineering +10